LTFS
CRL icon

Ladenburg Thalmann Financial Services’s Charles River Laboratories CRL Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$579K Sell
3,934
-72
-2% -$9.97K ﹤0.01% 1683
2019
Q3 		$528K Buy
4,006
+631
+19% +$84.6K ﹤0.01% 1721
2019
Q2 		$480K Buy
3,375
+122
+4% +$16.5K ﹤0.01% 1781
2019
Q1 		$479K Sell
3,253
-215
-6% -$28.2K ﹤0.01% 1721
2018
Q4 		$394K Buy
3,468
+1,745
+101% +$218K ﹤0.01% 1713
2018
Q3 		$230K Sell
1,723
-175
-9% -$21.6K ﹤0.01% 2202
2018
Q2 		$203K Hold
1,898
– – ﹤0.01% 2220
2018
Q1 		$203K Buy
1,898
+375
+25% +$40.4K ﹤0.01% 2220
2017
Q4 		$167K Buy
1,523
+181
+13% +$19.7K ﹤0.01% 2335
2017
Q3 		$145K Buy
1,342
+548
+69% +$56.3K ﹤0.01% 2344
2017
Q2 		$80K Buy
794
+7
+0.9% +$644 ﹤0.01% 2656
2017
Q1 		$71K Buy
787
+353
+81% +$30K ﹤0.01% 2635
2016
Q4 		$35K Sell
434
-62
-13% -$4.71K ﹤0.01% 3100
2016
Q3 		$41K Sell
496
-38
-7% -$3.19K ﹤0.01% 2929
2016
Q2 		$44K Buy
534
+31
+6% +$2.55K ﹤0.01% 2769
2016
Q1 		$39K Sell
503
-10
-2% -$740 ﹤0.01% 2763
2015
Q4 		$40K Buy
513
+27
+6% +$1.95K ﹤0.01% 2728
2015
Q3 		$31K Buy
486
+41
+9% +$2.94K ﹤0.01% 2795
2015
Q2 		$31K Sell
445
-51
-10% -$3.77K ﹤0.01% 2920
2015
Q1 		$39K Sell
496
-8
-2% -$590 ﹤0.01% 2739
2014
Q4 		$35K Buy
504
+48
+11% +$3.01K ﹤0.01% 2587
2014
Q3 		$27K Buy
456
+36
+9% +$2.06K ﹤0.01% 2431
2014
Q2 		$22K Buy
420
+47
+13% +$2.58K ﹤0.01% 2582
2014
Q1 		$23K Sell
373
-38
-9% -$2.21K ﹤0.01% 2472
2013
Q4 		$22K Hold
411
– – ﹤0.01% 2469
2013
Q3 		$21K Sell
411
-212
-34% -$9.73K ﹤0.01% 2405
2013
Q2 		$27K Buy
+623
New +$26.7K ﹤0.01% 2150

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CRL Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Charles River Laboratories (CRL) stake by 1.8% in Q4 2019, selling an estimated $9.97K and leaving 3,934 shares worth $579K. The position accounts for ﹤0.01% of the portfolio, ranked #1683.

Ladenburg Thalmann Financial Services first reported a position in CRL in Q2 2013 and has held it in 27 quarters since. 413 funds tracked by Wall St. Rank hold CRL as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 3,934 shares of Charles River Laboratories worth $579K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 72 Charles River Laboratories shares in Q4 2019, an estimated $9.97K.
  • Charles River Laboratories made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #1683 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Charles River Laboratories in Q2 2013 and has held it in 27 quarters since.
  • 413 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.